Biopharmaceutical CAGR turnover in the United Kingdom (UK) 2011-2016, by segment

Compound annual growth rate of turnover in the biopharmaceutical sector in the United Kingdom (UK) in 2016, by segment

Biopharmaceutical CAGR turnover in the United Kingdom (UK) 2011-2016, by segment This statistic displays the compound annual growth rate (CAGR) of turnover in segments of the biopharmaceutical sector in the United Kingdom (UK) between 2011 and 2016. The biopharmaceutical sector researches and produces pharmaceutical medications which are extracted or semi-synthesized from a biological source. These can include vaccines, antibodies, blood and tissue products and therapeutic proteins. The advanced therapy medicinal products segment experienced the highest growth rate during the five year period at 35 percent. This was followed by the therapeutic proteins segment at 16 percent. Both the vaccines and small molecules segment saw a decline of five percent during the five year period.
Show more

Compound annual growth rate of turnover in the biopharmaceutical sector in the United Kingdom (UK) in 2016, by segment

Loading statistic...
Compound annual growth rate (CAGR)
Therapeutic proteins16%
Vaccines-5%
Antibodies4%
Small Molecules-5%
Service and supply chain5%
Advances therapy medicinal products35%
Compound annual growth rate (CAGR)
Therapeutic proteins16%
Vaccines-5%
Antibodies4%
Small Molecules-5%
Service and supply chain5%
Advances therapy medicinal products35%
Download Settings Share
Download started
Please be patient - this may take a moment
This statistic displays the compound annual growth rate (CAGR) of turnover in segments of the biopharmaceutical sector in the United Kingdom (UK) between 2011 and 2016. The biopharmaceutical sector researches and produces pharmaceutical medications which are extracted or semi-synthesized from a biological source. These can include vaccines, antibodies, blood and tissue products and therapeutic proteins. The advanced therapy medicinal products segment experienced the highest growth rate during the five year period at 35 percent. This was followed by the therapeutic proteins segment at 16 percent. Both the vaccines and small molecules segment saw a decline of five percent during the five year period.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Medical technology in the United Kingdom"
  • Overview
The most important statistics
  • Turnover
  • Expenditure
  • Companies
  • Employment
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.